Z16.1 - Resistance to beta lactam antibiotics
- Applicable to Resistance to beta lactam antibiotics
- The 2025 edition of ICD10-CM Z16.1 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z16.1 - other international versions of ICD10 Z16.1 may differ.
- Z16.1 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z16.1 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z16.1 - Resistance to beta lactam antibiotics
- Z16.1 - Resistance to beta lactam antibiotics
- Z16.10 - Resistance to unspecified beta lactam antibiotics
- Z16.11 - Resistance to penicillins
- Z16.12 - Extended spectrum beta lactamase (ESBL) resistance
- Z16.13 - Resistance to carbapenem
- Z16.19 - Resistance to other specified beta lactam antibiotics
Non-Billable/Non-Specific Code
The following codes above Z16.1 contain annotation back-references that may be applicable to Z16.1:
- Chapter: Z00-Z99 - Factors influencing health status and contact with health services
- Section: Z16 - Resistance to antimicrobial drugs
- Category: Z16 - Resistance to antimicrobial drugs
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com